Literature DB >> 11823055

Expression of Ca2+/calmodulin-dependent protein kinase (CaMK) Ibeta2 in developing rat CNS.

A A Jusuf1, H Sakagami, T Terashima.   

Abstract

We observed the onset time and distribution pattern of beta2 isoform of Ca2+/calmodulin-dependent protein kinase I (CaMKIbeta2) in the CNS of the rat during the embryonic period until birth using an immunohistochemical method. The expression of CaMKIbeta2 started at embryological day 10 when the three primary brain vesicles and neural tube are generated from the neural plate. During the embryonic period, highly immunoreactive products were ubiquitously detected in neurons in the CNS, although neurons in the caudate-putamen and globus pallidus were faintly immunostained or immunonegative. High expression of CaMKIbeta2 persisted in the olfactory bulb, lymbic system, neocortex, septal nuclei, amygdala complex, some hypothalamic nuclei, pontine nuclei, Purkinje cells and granule cells in the cerebellar cortex through the developing period. At the subcellular level, CaMKIbeta2 was strongly expressed in nuclei of neurons but faintly in their cytoplasm, suggesting that this protein has an important role in the nuclear signaling pathway. This study demonstrates that expression of CaMKIbeta2 begins at the earliest developmental stage of the rat CNS and persists through the developing period.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11823055     DOI: 10.1016/s0306-4522(01)00514-0

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  2 in total

1.  Pregnancy-upregulated nonubiquitous calmodulin kinase induces ligand-independent EGFR degradation.

Authors:  Tushar B Deb; Christine M Coticchia; Robert Barndt; Hong Zuo; Robert B Dickson; Michael D Johnson
Journal:  Am J Physiol Cell Physiol       Date:  2008-06-18       Impact factor: 4.249

2.  Transcriptomic Analysis and Meta-Analysis of Human Granulosa and Cumulus Cells.

Authors:  Tanja Burnik Papler; Eda Vrtacnik Bokal; Ales Maver; Andreja Natasa Kopitar; Luca Lovrečić
Journal:  PLoS One       Date:  2015-08-27       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.